readthroughSign in
CompanyBDTXNasdaqCambridge, MA

Black Diamond Therapeutics, Inc.

Black Diamond Therapeutics is a clinical-stage oncology company developing small-molecule kinase inhibitors targeting oncogenic mutations.

10-QNov 16Latest SEC filing
Nov 9Latest story